Intra-operative Inspiratory Oxygen Fraction and Postoperative Respiratory Complications

NCT02399878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70000

Last updated 2016-03-31

No results posted yet for this study

Summary

Respiratory complications represent the second most frequent type of postoperative complications with an incidence estimated to range from 2.0% to 7.9%

It has been shown that intra-operative protective ventilation is associated with a reduced risk of respiratory complications. The effects of intra-operative inspiratory oxygen fraction (FiO2) remain to be investigated.

In this study, the investigators aim to investigate the association between intra-operative FiO2 and respiratory complication as well as surgical site infection and ICU admission in patients undergoing non-cardiothoracic surgery. The investigators primary hypothesis is that high intra-operative FiO2 increases the risk of postoperative respiratory complications independent of predefined risk factors.

Conditions

Interventions

DRUG

Inspiratory oxygen

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Matthias Eikermann, MD, PhD · MGH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2014-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399878 on ClinicalTrials.gov